thyroid
Thyroid Stimulating Hormone
A concise starting point for reading Thyroid Stimulating Hormone results within a thyroid-focused context.
- Short name
- TSH
- Unit
- mIU/L
- Reference min
- 0.4
- Reference max
- 4.0
- Optimal min
- 1.0
- Optimal max
- 2.5
- Better when
- in range
- Reference min (male)
- 0.4
- Reference max (male)
- 4.0
- Reference min (female)
- 0.4
- Reference max (female)
- 4.0
- Sample
- serum
- Fasting required
- false
- Related markers
- Free Thyroxine, Free Triiodothyronine, Total Thyroxine, Total Triiodothyronine
Moved by
Interventions that trials measured against this marker, and which way it moved.No trial has measured Thyroid Stimulating Hormone against an intervention in this library yet.
Via effects
Interventions targeting an effect this marker tracks. Trials did not measure the marker itself.Thyroid Health Support
Full write-up
What is it
Thyroid Stimulating Hormone (TSH) is a thyroid-related biomarker used as a starting point for reading results within a thyroid-focused context. Its role here is to help frame how thyroid-related findings are interpreted.
How to test it
Thyroid Stimulating Hormone is tested using a serum blood sample. Fasting is not required, so the test can be arranged without avoiding food beforehand. The laboratory reports the result in mIU/L and compares it with the reference and optimal ranges shown alongside the result.
Collection conditions still matter because the measurement depends on obtaining and processing the correct sample type. Follow the testing service’s instructions for the blood draw and tell the clinician about relevant health conditions or testing circumstances that may affect how the result is interpreted.
TSH may be considered alongside other thyroid-related measurements, including Free T4, Free T3, T4 Total, and T3 Total. These results can provide additional context rather than relying on TSH in isolation. A clinician can explain how the result fits the person’s symptoms, health history, and any other thyroid test findings.
Reading your result
Thyroid Stimulating Hormone results are interpreted by comparing the measured value with the reference range printed on the laboratory report. The reference range is the broader interval used to identify results that fall within the laboratory’s usual limits. A tighter optimal range may describe values considered preferable within that broader interval, but being outside the optimal range does not by itself mean that something is wrong.
Laboratories may use different reference ranges or units, so a number is meaningful only when read alongside the range and units shown on the same report. The result should also be considered in context rather than treated as a standalone conclusion: a single value is not a diagnosis, and an out-of-range result belongs with a clinician for interpretation.
What moves it
Direct measurements show that Iodine, Black Seed Oil, and Ashwagandha decreased Thyroid Stimulating Hormone. The Ashwagandha findings came from a study in animals, so they do not establish the same effect in people. Selenium, Melatonin, Resveratrol, Saffron Extract, and Yoga were unchanged overall in the direct evidence, although the Yoga review included studies reporting both significant and non-significant decreases. A decrease is not automatically beneficial because this marker is interpreted against an optimal range.
The direct studies generally reassessed Thyroid Stimulating Hormone from 5.7 to 80.0 weeks, with several interventions checked after 8 weeks. This range reflects substantial variation in follow-up timing rather than a single expected response time.
Separately, interventions listed for Thyroid Health Support target effects related to what this marker tracks, though trials did not measure Thyroid Stimulating Hormone directly in that group. Selenium, Yoga, and Ashwagandha are linked with improvements in related thyroid outcomes, while Iodine, Sea Moss (Irish Moss), and Tyrosine are described through their roles in thyroid hormone production or nutrient adequacy. These related-effect entries should not be treated as equivalent to direct evidence that an intervention changes this marker. Evidence is also not uniform in its applicability: some findings concern clinical conditions, while others are based on pharmacology references, reviews, or studies without human evidence. For a medical condition or an unexpectedly high or low result, interpretation with a clinician is appropriate.